Стоит ли инвестировать в биотехнологии?— Ивар ft. Илья Ясный | Мыслить как ученый #5

How does the biotech market work, and is it worth investing in? How does biotech differ from IT, and what factors influence the success of biotech startups? How do clinical trials work, and why can drug approvals drag on for years? This and much more awaits you in the new episode of PostNauka founder Ivar Maksutov's podcast, "Think Like a Scientist." The guest of the episode is Ilya Yasny, PhD in Chemistry, head of scientific expertise at LanceBio Ventures, and author and editor of the popular science project "Biomolecule." In this conversation, he shares his insights on biotech financing, the prospects for gene therapy, the role of regulators in the industry, and the challenges of going public. Ilya Yasny's Telegram channel: https://t.me/LanceBio 00:00 The Long Journey of Drug Development: From Idea to Market 01:54 Investor Interests in Biotech: What to Consider 05:52 Risks and Biases in Biotech Investing 09:11 The Drug Development Ecosystem: Who's Involved 12:46 The Drug Development Cycle: From Research to Clinical Trials 15:35 Biotech Financing: Venture Capital and Grants 18:31 The Path to an IPO: Prospects and Potential Risks for Investors 20:32 Differences Between Biotech and IT: What Investors Need to Consider 22:57 Successful Transformations of Biotech Companies 26:44 Regulators and Their Impact on the Biotech Market 30:04 How Company Interactions with Regulators Affect Innovation 32:48 The Role of the FDA in Approving New Drugs and Development Biotechnology 36:31 Drug safety and efficacy issues: what to look for? 38:56 Pharmacogenetics and its Impact on Personalized Drug Development 41:58 Drug Registration: The Role of Patient Subgroups and Clinical Data 42:52 Key Challenges in Diagnostics and Commercialization of Biotechnology 44:03 How to Invest in Biotech: Criteria for Selecting Promising Companies 45:22 Challenges in Antibiotic Development and Why It Matters 46:52 How to Solve the Problem of Antibiotic Resistance 49:08 Developing Antiviral Drugs and Vaccines: Industry Challenges 51:57 Why Investing in Vaccines is Complex and Requires a Long-Term Horizon 56:19 Treating Neurodegenerative Diseases: Key Challenges 59:43 Breakthroughs in Oncology: New Cancer Treatments 01:01:30 Investing in Neurodegenerative Disease Treatment 01:03:06 Gene Therapy: Prospects, Risks, and Barriers to Implementation 01:11:23 New Treatments for Autoimmune Diseases 01:13:42 Genome Editing: The Future of CRISPR Technologies 01:16:34 Economic and Cultural Barriers to Medical Development 01:19:31 The Future of Biotechnology: Prospects and Opportunities for Investors Subscribe to the channel: https://www.youtube.com/@postnauka/join PostNauka is an educational platform for those who consider scientific thinking the primary tool for understanding themselves and the world. Learn more: https://postnauka.org/link/main_yt Courses from the creators of PostNauka: https://postnauka.org/link/academy_yt Support PostNauka: https://postnauka.org/link/donate_yt Follow the news on Telegram: https://postnauka.org/link/telegram Advertising inquiries: https://postnauka.org/link/letsdance_yt #podcast #thinking #science #investments #biotech #biotechnology #IPO #vaccines #gene therapy #medicine #finance #startups